NL-OMON51140已完成不适用
In vitro potency of clinically used antiplatelet drugs in patients with Metabolic dysfunction Associated Fatty Liver Disease - Potency of AntiPlatelet drugs in patients with MAFLD (PAD-MAFLD)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Inclusion criteria study groups:
- •>= 18 years of age
- •Signed informed consent
- •Some degree of liver steatosis and fibrosis (FibroScan F1-F4) with or without
- •diagnosis of diabetes mellitus
- •Inclusion criteria control group:
- •>= 18 years of age
- •Signed informed consent
排除标准
- •Underlying liver disease with other aetiology than Metabolic dysfunction
- •Associated Fatty Liver Disease
- •Use of anti-platelet (salicylates, P2Y12 inhibitors, dipyridamole) or
- •anti-hemostatic (heparins, vitamin K antagonists, direct oral anticoagulants)
- •Use of Non-Steroid Anti-Inflammatory Drugs 4 days prior to inclusion
- •Documented history of hereditary thrombophilia or haemophilia
- •Current malignancy
- •Pregnancy
- •Pre-existing immunosuppressive status (HIV positivity, previous solid organ
- •transplant)
- •Transfusion of blood products 7 days prior to inclusion
- •Not willing to be notified of FibroScan results
研究者
相似试验
尚未招募
不适用
Potency of Antiplatelet Drugs in MAFLDNL-OMON21913MCG160
招募中
不适用
Study on the responsiveness of antiplatelet drugs in patients with cerebral infarction.oncardioembolic ischemic strokeJPRN-UMIN000005997Keio University School of Medicine Department of Neurology200
已完成
不适用
Study on Therapeutic Effects of Antiplatelet Drugs in Prevention of Occurrence and Inhibition of Progression of Diabetic AtherosclerosisDiabetesJPRN-C000000215DAPC Study Steering Committee400
已完成
4 期
The efficacy and safety of the antiplatelet therapy in acute non-cardiogenic ischemic stroke.on-cardiogenic ischemic stroke in acute phase.JPRN-UMIN000006931Department of Neurosurgery, Faculty of Medicine, University of Tsukuba130
进行中（未招募）
1 期
The effect of antiplatelet therapy after angioplasty.EUCTR2016-002086-54-NLniversity Medical Center Utrecht1,806